Company: ARTL
Filing Date: 2025-08-20
Form Type: 8-K
Source: 0001640334-25-001570
Chunk: 0

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-08-20
Form: 8-K
Item: Item 1.02
Chunk 0
---
Item 1.02 Termination of a Material Definitive Agreement.

Termination of Securities Purchase Agreement

As previously disclosed, Artelo Biosciences, Inc. (the “ Company”) entered into a Securities Purchase Agreement dated as of August 1, 2025 (the “ Purchase Agreement”) with certain accredited investors (the “ Investors”), pursuant to which the Company agreed to issue and sell, in a private placement (the “ Offering”): (i) 593,252 shares (the “ Shares”) of the Company’s common stock, par value $0.001 per share (the “ Common Stock”), and (ii) warrants to purchase up to 2,126,809 shares of Common Stock (the “ Purchase Warrants”). A description of the Purchase Agreement was disclosed in the Company’s Current Report on Form 8-K, filed with the U. S. Securities and Exchange Commission (the “ SEC”) on August 4, 2025.

On August 19, 2025 (the “ Effective Date”), the Company entered into a Termination and Mutual Release Agreement (the “ Purchase Termination Agreement”) with the Investors. The Purchase Termination Agreement terminates in its entirety, effective as of the Effective Date, the Purchase Agreement, the Purchase Warrants, and any other certificates, agreements, or instruments executed in connection therewith (collectively, the “ Purchase Documents”).

Pursuant to the Purchase Termination Agreement, the Purchase Documents are deemed null and void from inception and of no further force or effect (except for certain customary provisions that survive solely with respect to the Purchase Termination Agreement). The Company and the Investors mutually released each other and their respective affiliates from all claims that either might have against the other except for claims relating to any breach by the Company of the representations, warranties or covenants made in any of the transaction documents relating to the private placement transaction that occurred in June 2025 in which one or more of the Investors may have participated. The Company is required to return any portion of the purchase price under the Purchase Agreement previously received (if any) to the Investors’ counsel’s trust account within three business days after the Effective Date. Concurrently with execution of the Purchase Termination Agreement, the Company paid $50,000 to TingleMerrett LLP, counsel to the Investors, for legal fees incurred in connection with the transaction. No termination penalties are payable by either party. Each party will bear its own transaction expenses, other than the legal fee payment described above.

A copy of the